BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

780 related articles for article (PubMed ID: 30384259)

  • 1. New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis.
    Yuan T; Yang T; Chen H; Fu D; Hu Y; Wang J; Yuan Q; Yu H; Xu W; Xie X
    Redox Biol; 2019 Jan; 20():247-260. PubMed ID: 30384259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus.
    Katakami N
    J Atheroscler Thromb; 2018 Jan; 25(1):27-39. PubMed ID: 28966336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress and diabetic complications.
    Giacco F; Brownlee M
    Circ Res; 2010 Oct; 107(9):1058-70. PubMed ID: 21030723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Glycemic Indices (Hyperglycemia, Glucose Variability, and Hypoglycemia) with Oxidative Stress and Diabetic Complications.
    Papachristoforou E; Lambadiari V; Maratou E; Makrilakis K
    J Diabetes Res; 2020; 2020():7489795. PubMed ID: 33123598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress, AGE, and atherosclerosis.
    Schleicher E; Friess U
    Kidney Int Suppl; 2007 Aug; (106):S17-26. PubMed ID: 17653206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes.
    Shah MS; Brownlee M
    Circ Res; 2016 May; 118(11):1808-29. PubMed ID: 27230643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis impairment by the NADPH oxidase-triggered oxidative stress at the bone-implant interface: Critical mechanisms and therapeutic targets for implant failure under hyperglycemic conditions in diabetes.
    Hu XF; Wang L; Xiang G; Lei W; Feng YF
    Acta Biomater; 2018 Jun; 73():470-487. PubMed ID: 29649637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach.
    Folli F; Corradi D; Fanti P; Davalli A; Paez A; Giaccari A; Perego C; Muscogiuri G
    Curr Diabetes Rev; 2011 Sep; 7(5):313-24. PubMed ID: 21838680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of miR-92a Suppresses Oxidative Stress and Improves Endothelial Function by Upregulating Heme Oxygenase-1 in db/db Mice.
    Gou L; Zhao L; Song W; Wang L; Liu J; Zhang H; Huang Y; Lau CW; Yao X; Tian XY; Wong WT; Luo JY; Huang Y
    Antioxid Redox Signal; 2018 Feb; 28(5):358-370. PubMed ID: 28683566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and signaling mechanisms of atherosclerosis in insulin resistance.
    Schwartz EA; Reaven PD
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):525-49, viii. PubMed ID: 16959584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac oxidative stress in diabetes: Mechanisms and therapeutic potential.
    Faria A; Persaud SJ
    Pharmacol Ther; 2017 Apr; 172():50-62. PubMed ID: 27916650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation: a novel outlook on atherosclerosis.
    Price CL; Knight SC
    Curr Pharm Des; 2007; 13(36):3681-7. PubMed ID: 18220806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperglycemia and the pathobiology of diabetic complications.
    Aronson D
    Adv Cardiol; 2008; 45():1-16. PubMed ID: 18230953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.
    Basta G; Schmidt AM; De Caterina R
    Cardiovasc Res; 2004 Sep; 63(4):582-92. PubMed ID: 15306213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of a novel mechanism of diabetic complications: impacts of mitochondrial reactive oxygen species].
    Nishikawa T; Araki E
    Rinsho Byori; 2008 Aug; 56(8):712-9. PubMed ID: 18800628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive oxygen species: sources, consequences and targeted therapy in type 2 diabetes.
    Panigrahy SK; Bhatt R; Kumar A
    J Drug Target; 2017 Feb; 25(2):93-101. PubMed ID: 27356044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological Perturbations in Diabetic Retinopathy: Hyperglycemia, AGEs, Oxidative Stress and Inflammatory Pathways.
    Sahajpal NS; Goel RK; Chaubey A; Aurora R; Jain SK
    Curr Protein Pept Sci; 2019; 20(1):92-110. PubMed ID: 30264677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress.
    Rolo AP; Palmeira CM
    Toxicol Appl Pharmacol; 2006 Apr; 212(2):167-78. PubMed ID: 16490224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irisin Alleviates Advanced Glycation End Products-Induced Inflammation and Endothelial Dysfunction via Inhibiting ROS-NLRP3 Inflammasome Signaling.
    Deng X; Huang W; Peng J; Zhu TT; Sun XL; Zhou XY; Yang H; Xiong JF; He HQ; Xu YH; He YZ
    Inflammation; 2018 Feb; 41(1):260-275. PubMed ID: 29098483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis.
    Förstermann U; Xia N; Li H
    Circ Res; 2017 Feb; 120(4):713-735. PubMed ID: 28209797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.